MENU

Click below to download The Novozymes Report 2015 in PDF format.

  •  The big picture
  •  Our business
  •  Governance
  •  Accounts and performance
  •  Supplementary

Executive Leadership Team

Peder Holk Nielsen

Born 1956. President & CEO.

Board positions 

Member:
Hempel A/S
LEO Pharma A/S

Education

Holds a Ph.D. and an M.Sc. in Chemical Engineering from the Technical University of Denmark (DTU) and a B.Com. in International Business Management from Copenhagen Business School.

Special competencies

Novozymes’ CEO since 2013. Peder focuses on developing our organization and processes to effectively turn customer insights into product ideas and solutions that excite Novozymes’ customers. With his background in engineering and business management, Peder drives an agenda and leadership style that couple market insights and research capabilities in order to deliver innovation that contributes to Novozymes’ growth strategy.

Per Falholt

Born 1958. Executive Vice President, Research & Development.

Board positions

Chairman:
Technical University of Denmark (DTU)

Member:
DHI Group
Emerald Technology Ventures

Education

Holds an M.Sc. in Chemical Engineering from the Technical University of Denmark (DTU).

Special competencies

Per leads Novozymes' R&D organization, which serves numerous industries from sites worldwide. Per has a passion and vision for chemistry and biotechnology, and an in-depth knowledge of product development within the enzyme industry and application know-how. He has helped Novozymes develop a unique industrial biotechnology platform that delivers solutions to meet customer needs and support growth.

Andrew Fordyce

Born 1963. Executive Vice President, Business Operations.

Education

Holds a Ph.D. in Chemical Engineering from the University of Texas at Austin.

Special competencies

Responsible for global sales, marketing and technical service as well as strategic communication with customers, employees and stakeholders worldwide, Andrew’s role is to grow established industries by using Novozymes’ technological capabilities to best meet customers’ business needs. Andrew’s career has moved from pure engineering to a strong focus on value generation for customers. Previous responsibilities include global sales, strategic account management and technical service strategy.

Benny D. Loft

Born 1965. Executive Vice President & CFO.

Board positions

Member:
DONG Energy A/S
New Xellia Group A/S

Chairman of the Audit Committee:
DONG Energy A/S
New Xellia Group A/S

Education

State-authorized Public Accountant.

Special competencies

Benny leads Corporate Functions, which covers finance, investor relations, legal, IT, human resources and facility management. Benny combines a wealth of financial experience and acumen with extensive operational knowledge of the company’s core business areas. He played a central role in the demerger of Novozymes from Novo Nordisk in 2000, and was also responsible for building Novozymes’ finance department in the same period.

Thomas Nagy

Born 1963. Executive Vice President, Supply Operations.

Board positions

Member:
American Chamber of Commerce in Denmark
Bio-based Industries Joint Undertaking (BBI JU)

Education

Holds a B.Sc. in Chemical Engineering from the Technical University of Denmark (DTU) and is a graduate of the Wharton School of Business AMP program.

Special competencies

Thomas is responsible for sourcing, production, supply chain, process optimization, engineering and quality, and aims to deliver consistent, high-value solutions to customers. Thomas has extensive and international experience in leading and facilitating business and technology strategy development, and corporate operational improvement programs focusing on capacity improvement and cost optimization. Previous responsibilities include stakeholder relations, including global communications, human resources and public affairs. He also has a particular insight into the vital U.S. market.

Thomas Videbæk

Born 1960. Executive Vice President, Business Development.

Board positions

Member:
Evolva SA
Beta Renewables S.p.A

Chairman of the Audit Committee:
Beta Renewables S.p.A

Education

Holds a Ph.D. and an M.Sc. in Chemical Engineering from the Technical University of Denmark (DTU) and a B.Com. in International Business from Copenhagen Business School. 

Special competencies

Thomas is responsible for business development and nurturing and realizing the potential of Novozymes’ new platforms. With an eye for the next big idea and business solution, Thomas has been a central figure in business ventures outside Novozymes’ established areas. He also has a broad knowledge of sales & customer solutions and supply chain operations.